Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients

NCT03004209 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Autoimmune Encephalitis

Interventions

DRUG: Erythropoietin

Sponsor

Seoul National University Hospital